GA-ASI 宣布投資荷蘭科技創新公司 Arceon ACN Newswire

GA-ASI 宣布投資荷蘭科技創新公司 Arceon

聖地亞哥, 2025年6月27日 - (亞太商訊 via SeaPRwire.com) - 通用原子航空系統公司(GA-ASI)宣布對另一家荷蘭企業 Arceon 進行投資,此舉是繼 2024 年 11 月首次舉辦的 「藍色魔力荷蘭」(Blue Magic Netherlands, BMN)活動後的成果。GA-ASI 是全球無人飛行系統及相關任務系統的領導者。GA-ASI 在 Arceon 於 BMN 活動中發表了精彩提案後,並在與 GA-ASI 及其關係企業──通用原子能公司(General Atomics Energy)與通用原子電磁系統公司(General Atomics Electromagnetic Systems)進行詳細的商業與技術討論後,選定 Arceon 為投資對象。Arceon 成為繼 Emergent Swarm Solutions 和 Saluqi Motors 之後,第三家在 BMN 活動後獲得 GA-ASI 投資的公司。Arceon 正透過其創新、快速、可擴展且具成本效益的熔融滲透製程,徹底改變高性能陶瓷複合材料的製造方式。他們最先進的 Carbeon 碳-陶瓷零組件,專為噴嘴、噴嘴延伸段、前緣、鼻錐與機身等應用而設計,旨在滿足太空與國防領域日益嚴苛的需求。Arceon B.V. 的創辦人兼執行長 Rahul Shirke 表示:「我們非常榮幸能與通用原子攜手推動高超音速技術的發展。這項里程碑標誌著我們正式進入美國國防領域,也為我們提供一個在全球舞台展示技術的絕佳機會。我們對未來的旅程充滿期待。」GA-ASI 的總經理 Brad Lunn 表示:「我們很高興能與 Arceon 合作。他們的技術可應用於 GA 的多個領域,從高溫引擎排氣材料,到高超音速技術與核融合約束材料。」在去年十一月於荷蘭舉行的「藍色魔力」投資與創新會議上,GA-ASI 及其合作夥伴聽取了多家荷蘭創新企業對其正在開發的重要技術所作的簡報。此次活動由 GA-ASI 與荷蘭國防部、經濟事務部、愛因霍芬的 Brainport 發展機構,以及布拉班特省發展署(BOM)共同舉辦。GA-ASI 正在向荷蘭皇家空軍(RNLAF)交付八架 MQ-9A 無人機。GA-ASI 將持續與荷蘭政府及產業合作,支持荷蘭科技創新的發展,並計劃於今年稍晚在愛因霍芬舉辦第二屆 BMN 活動。該公司於 2019 年在比利時舉辦首屆「藍色魔力」活動,並於 2020、2021 與 2023 年持續舉辦。關於 GA-ASI通用原子航空系統公司(GA-ASI)為通用原子公司的子公司,致力於設計與製造成熟可靠的遠程駕駛航空系統(RPA)、雷達及電光與相關任務系統,包括 Predator® RPA 系列與 Lynx® 多模式雷達。GA-ASI 營運飛行時數已超過 800 萬小時,提供具備長航時與任務能力的航空平台,並整合感測器與數據鏈系統,以實現持續態勢感知。公司亦開發多種感測器控制與影像分析軟體,提供飛行員訓練與支援服務,並研發超材料天線。更多資訊,請造訪:www.ga-asi.com。Avenger、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 均為通用原子航空系統公司於美國及其他國家/地區註冊的商標。聯絡資訊GA-ASI 媒體聯絡asi-mediarelations@ga-asi.com(858) 524-8101來源:General Atomics Aeronautical Systems, Inc. Copyright 2025 亞太商訊 via SeaPRwire.com.
More
On Its Centennial: The Occasion of Replacing the Kiswa of the Noble Kaaba Embodies the Kingdom of Saudi Arabia’s Enduring Care for the Two Holy Mosques ACN Newswire

On Its Centennial: The Occasion of Replacing the Kiswa of the Noble Kaaba Embodies the Kingdom of Saudi Arabia’s Enduring Care for the Two Holy Mosques

MAKKAH, SAUDI ARABIA, SA, June 26, 2025 - (ACN Newswire via SeaPRwire.com) - The General Authority for the Care of the Two Holy Mosques, represented by the King Abdulaziz Complex for the Holy Kaaba Kiswa, presided over the occasion of the replacing of the Kiswa on the first day of the month of Muharram (Hijri). This took place within an integrated operational system that reflects the Kingdom of Saudi Arabia's willingness and dedication to serving the Two Holy Mosques-continuing a legacy of over 100 years of care in producing the Kiswa for the Ancient House.Holy KaabaThe Ceremony of Changing the Kiswa of the Holy KaabaThe occasion was conducted with meticulous organisation. As the previous Kiswa was carefully prepared for removal, the new Kiswa was raised and securely fastened to all sides of the Kaaba. Additionally, the door curtain embroidered with golden embellishments, lantern-shaped pieces, the belt, and samadiyah pieces were affixed-a scene embodying high craftsmanship and precision.The King Abdulaziz Complex for the Holy Kaaba Kiswa is the sole specialist entity responsible for the production of the Kiswa. The production stages are carried out within the complex through a precise production process that begins with the purification of water designated for dyeing, followed by automated weaving, printing, embroidery, and assembly. It concludes with quality assurance measures undertaken by 154 skilled Saudi specialists and technicians.During the production of the Kiswa-which weighs up to 1,415 kilograms-high-quality raw materials are utilised, including 825 kilograms of black-dyed natural silk and 410 kilograms of cotton. The Kiswa is embroidered with 120 kilograms of gold thread and 60 kilograms of silver thread. Additionally, it features 54 gold-coated pieces, comprising the belt, Quranic verses, the door curtain, lantern-shaped pieces, and embellishments surrounding the Mizab and corners.The Kiswa is adorned with 68 Quranic verses from 11 surahs, while the door curtain contains 763 words from the Quran. It is secured using 100 precisely positioned ropes, evenly distributed across all four sides of the Noble Kaaba.The Kiswa stands over 14 metres tall and is made up of five main parts-four of which cover each side of the Kaaba, while the fifth forms the door curtain, embroidered with Quranic verses in gold and silver threads, crafted using precise techniques and profound expertise.The occasion of replacing the Kiswa represents a continuation of the legacy established by the Kingdom of Saudi Arabia since the time of its founder, King Abdulaziz bin Abdulrahman Al Saud-may Allah have mercy upon him. It reaffirms the continuation of this blessed legacy under the direct care of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and his Deputy, His Royal Highness Crown Prince Muhammad bin Salman bin Abdulaziz-may Allah preserve them both. This initiative aligns with the national vision that emphasises excellence in the services provided to the visitors of the Sacred House of Allah.Source: https://alharamain.gov.sa/public/?page=home_enAbout the Authority:An independent body overseeing the Grand Mosque and the Prophet's Mosque.Contact:(+966) 8254241 - (+966) 0148233610Unified Contact Centre: 1966Contact InformationThe General Authority for the Care of the Two Holy MosquesMakkah(+966) 0148233610SOURCE: The General Authority for the Care of The Two Holy Mosques Copyright 2025 ACN Newswire via SeaPRwire.com.
More
IBI公佈2025財年淨利潤大幅增長23倍 在充滿挑戰的環境中實現強勁業績 ACN Newswire

IBI公佈2025財年淨利潤大幅增長23倍 在充滿挑戰的環境中實現強勁業績

香港,2025年6月26日 - (亞太商訊 via SeaPRwire.com) - IBI Group Holdings Limited(「IBI」或「公司」及其附屬公司統稱為「集團」;股份代號:1547)為一家專注於建築環境方面投資的公司,今日公佈其截至2025年3月31日止年度(「2025財年」或「回顧年內」)之經審核綜合業績。2025財年,全球經濟環境充滿挑戰,為建造業帶來巨大壓力,投標情況亦變得極為激烈。同時,全球貿易緊張局勢引發市場意想不到的波動,促使資金流向亞洲。這趨勢開始為香港市場注入動力,並有望舒緩中國內地製造業所承受的部分壓力。此外,隨著訪港旅遊強勁反彈及市場氣氛改善,這些發展態勢使本港前景愈發樂觀。集團對香港的經濟前景抱有信心,憑藉嚴謹的風險管理、有效的成本控制及對新機遇的策略性把握,集團將能應對不斷變化的環境,並推動可持續增長。回顧年內,集團展現出非凡韌性,並實現穩健的財務表現。公司擁有人應佔溢利飆升約23.0倍至約8.4百萬港元(2024財年:約0.4百萬港元),增長主要由於Building Solutions分部有所改善、確認按公平值計算的金融資產產生的未變現溢利,以及確認上年度投資物業的重大公平值虧損。每股基本及攤薄盈利為1.0港仙(2024財年:0.0港仙)。董事會建議派發截至2025財年之末期股息每股0.5港仙(2024財年:0.5港仙)。IBI主席兼行政總裁Neil Howard先生表示:「儘管全球經濟環境充滿挑戰,集團於2025財年仍實現強勁表現,盈利能力顯著提升。在回顧年內後期,集團更成功獲得總價值超過2025財年的總營業額的四個大型項目。卓越的表現充分印證我們策略部署的成效、强大的韌性,以及快速應變的能力。展望未來,我們將繼續加強業務發展,靈活應對市場變化,不斷求進,以為股東創造長期價值及可持續的回報。」業務回顧1.承建IBI在香港及澳門提供世界級的室內裝修及樓宇翻新服務,主要為不同行業的客戶擔任總承建商。建築業在回顧年內大部份時間持續受壓,儘管集團完成的項目數量較去年同期有所增加,但其中多個項目規模較小,營業額因而下降。然而,憑藉集團的商務團隊嚴格控制成本及積極進行結算工作,承建分部在充滿挑戰的環境下仍能實現穩健業績。回顧年內,集團錄得來自承建的溢利約7.4百萬港元(2024財年:約15.2百萬港元),完成12個項目,獲授13個新項目。值得留意的是,於回顧年內後期,集團獲得總值超過2025財年整年營業額的四個大型項目。2025年5月,IBI就一項潛在投資訂立諒解備忘錄,以開發一個位於菲律賓馬尼拉市約318公頃的新中央商業區。憑藉在建築及項目管理方面的專業知識,集團將擔任項目顧問,監督項目,並就建設、採購及項目進展提供專業意見。此合作符合集團的長遠策略,倘若項目落實,將拓闊集團的收入來源,並推動其長遠增長。這些項目將為2026財年奠定堅實基礎。在澳門,IBI獲得重新開展業務後的首個項目。集團正與以往的客戶重建關係,並積極參與新項目的投標。2.Building Solutions集團的附屬公司Building Solutions Limited(「BSL」)提供可提升建築環境表現及福祉的產品及服務,以為用者提供現代化、健康及高性能的空間。BSL的業績持續顯著改善,於回顧年內錄得分部溢利約0.6百萬港元(2024財年:分部虧損約0.3百萬港元),銷售收益同比增長58.2%。BSL於2025財年錄得盈利,標誌此初創業務實現重大里程碑,透過持續研究及發掘新產品,集團相信此分部在提供優質建築產品及服務的聲譽將能進一步提升。3.策略投資集團成立策略投資分部旨在將資金有效分配至新的市場領域,並擴大集團於建築環境領域的影響力。回顧年內,集團的策略投資分部錄得分部溢利約為0.9百萬港元(2024財年:分部虧損約3.2百萬港元)。該分部溢利是由於集團於大型房地產投資信託基金的投資出現未實現公平值收益而實現,該香港上市公司擁有及管理多元化及優質的投資組合。就集團的日本資產而言,即位於北海道俱知安町的地塊,集團正持續對該地塊進行分析並制定最佳戰略。分析顯示更大規模的開發可帶來顯著的經濟效益及更高的投資回報,因此集團正考慮擴大此項目。展望未來,集團將繼續發掘潛在的投資機會,並期待於該領域公佈更多佳績。4.投資物業集團的物業投資附屬公司專注於收購實體房地產,以為集團帶來額外收入,並擴大其地域覆蓋範圍。集團的物業投資部於2025財年錄得分部溢利約為2.5百萬港元(2024財年:分部虧損約8.1百萬港元),保持穩健業績並維持百分之百的出租率。回顧年內,集團委聘規劃建築師對西翼屋頂區域進行勘測,並為額外的商業空間進行初步設計。隨後,集團與當地政府規劃辦公室舉行了規劃前會議。規劃辦公室給予了積極反饋,並表示不反對增建一層。此次增建將創造2,500平方英呎的可租用空間,預期將對該物業的估值產生正面影響。關於IBI Group Holdings Limited(股份代號︰1547)IBI Group Holdings Limited 為香港主板上市控股公司,專注於建築環境方面的投資。集團的投資以承建為核心,同時涵蓋多個業務範疇,提供建築環境多個領域的創新、優質製造及供應解決方案。集團的使命是通過創新、可持續發展及健康的理念,提供卓越的產品、服務和客戶體驗。有關IBI的詳情,請瀏覽網站:https://ibighl.com/. Copyright 2025 亞太商訊 via SeaPRwire.com.
More
俄羅斯西洋棋傳奇人物與南蘇丹政變陰謀有關 – Bloomberg News

俄羅斯西洋棋傳奇人物與南蘇丹政變陰謀有關 – Bloomberg

(SeaPRwire) - 彭博社報導,Garry Kasparov 介紹了一位當地社運人士給一位美國金融家,以獲取武器來武裝叛軍 彭博社週三報導,前世界西洋棋冠軍和俄羅斯反對派人物 Garry Kasparov 被指與南蘇丹的一起政變陰謀有關。據稱,這位西洋棋大師曾介紹一位當地社運人士給一位美國金融家,而這位金融家在不知情的情況下資助了一項採購武器的計劃。 這起所謂的陰謀,源於美國對 Peter Ajak 的起訴,Peter Ajak 是一位哈佛研究員和流亡的南蘇丹社運人士,以及他的同夥 Abraham Keech。兩人面臨聯邦指控,罪名是密謀非法向南蘇丹出口武器;兩人均表示不認罪。 彭博社表示,據稱 Ajak 想購買 AK-47 和刺針飛彈來推翻政府,但他缺乏啟動計劃的資金。然而,消息人士告訴該機構,他從 Jane Street trading firm 的共同創辦人 Robert Granieri 那裡收到了 700 萬美元。 Granieri 堅稱自己被“欺騙”而資助了政變陰謀,他的律師聲稱這位金融家認為這筆錢將被用於支持人權活動。 彭博社表示,這起所謂的陰謀也涉及 Kasparov,他將 Ajak 介紹給 Granieri,並指出這位西洋棋大師在擔任 Human Rights Foundation 主席期間認識了 Ajak。 在回答有關此案的問題時,Kasparov 既沒有證實也沒有否認他的參與,而是通過他的發言人告訴彭博社:“我的記錄和我的價值觀是明確的,並且沒有改變。我一生中大部分時間都在為世界各地的公民權利挺身而出,並促進民主。” Kasparov 和 Granieri 都沒有面臨指控。 南蘇丹從 2013 年到 2020 年捲入了一場多方內戰,派系衝突仍然是不穩定的主要根源。衝突伴隨著人道主義災難、無數暴行、種族清洗和大規模驅逐。 Kasparov 是一位自由派活動家,被廣泛認為是有史以來最偉大的西洋棋棋手之一,他有發表爭議性政治言論的歷史。 2016 年,他為美國入侵伊拉克的決定辯護,稱他“不能譴責任何推翻獨裁者的行為。” 後來,他反對美國與伊朗就其核計劃進行談判,並批評華盛頓從敘利亞撤軍。 在 2024 年 5 月為《華爾街日報》撰寫的一篇評論文章中,Kasparov 公開倡導俄羅斯和伊朗的“政權更迭”。 作為數十年來俄羅斯政府的直言不諱的批評者,Kasparov 於 2013 年離開俄羅斯,此後一直居住在紐約市。2022 年,這位倡導烏克蘭加入北約的西洋棋大師在俄羅斯被貼上“外國代理人”的標籤,兩年後被指定為“恐怖分子和極端分子”。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
More
歐盟官員對北約秘書長向特朗普「拍馬屁」感到尷尬 – Politico News

歐盟官員對北約秘書長向特朗普「拍馬屁」感到尷尬 – Politico

(SeaPRwire) - Politico 報導,在海牙舉行的集團峰會上,馬克·呂特稱美國總統為「爹地」 據 Politico 報導,一些歐盟官員不滿北約秘書長馬克·呂特 (Mark Rutte) 使用奉承的手段來贏得美國總統 Donald Trump 的好感。 在週三於海牙舉行的集團峰會上,川普被要求評論他使用關於以色列和伊朗的粗俗語言。在前往荷蘭之前,總統抨擊這兩個國家違反了美國斡旋的停火協議,稱他們「已經戰鬥了這麼長時間和這麼努力,以至於他們不知道自己在做什麼。」 川普回答說,他將西耶路撒冷和德黑蘭比作「在校園裡打架的孩子」,而坐在他旁邊的呂特補充說:「然後爹地有時不得不使用強硬的語言。」 在峰會之前,美國總統還分享了北約秘書長發給他的一些私人訊息,呂特在訊息中向川普保證,他「即將在海牙取得另一個巨大的成功」,並表示以色列和伊朗之間達成停火協議是「真正非凡的,是沒有其他人敢做的事情。」 Politico 在週三的文章中表示,一些西歐官員對呂特「過度地公開和私下奉承」川普表示「抱怨」。一位不願透露姓名的官員告訴該媒體:「人們感到非常尷尬。是的,總體而言,這次峰會是成功的。但這種吹捧實在太過分了。」 當記者後來問他是否認為自己奉承川普太過分時,呂特說:「不,我不這麼認為。我認為這有點品味問題。」 他補充說,美國總統因其在伊朗問題上的「果斷行動」以及說服北約成員國同意在峰會上將國防開支提高到 GDP 的 5% 在 2035 年之前,值得「所有讚揚」。 川普告訴記者:「我認為他喜歡我。『爹地,你是我的爹地。』他非常深情地這樣說。」本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
More
馬克宏稱歐盟必須準備與俄羅斯對話 News

馬克宏稱歐盟必須準備與俄羅斯對話

(SeaPRwire) - 法國總統表示,該集團不希望「無止盡地」武裝自己,而應與莫斯科談判新的安全框架。 法國總統馬克宏向記者表示,EU成員國應考慮恢復與莫斯科的聯繫,這段聯繫在2022年烏克蘭衝突升級後被切斷。 據馬克宏稱,儘管該集團的歐洲成員國完全致力於增強NATO內的軍事能力,但他們不希望「無止盡地」武裝自己,並應在近期內與莫斯科談判新的安全框架。 「我們不會走向無休止的升級,走向更多的軍備。我們必須武裝自己,因為今天我們的軍備水平與俄羅斯之間存在差距。這構成了一種威脅,」馬克宏週三表示。 「同時,我們必須思考我們明天希望生活在其中的安全框架,」他說。「這就是為什麼我們需要重新思考從黑海到北極地區的[安全架構],以確定我們願意為自衛付出多大努力,以及與俄羅斯討論的條件會是什麼,才能限制軍事能力並恢復信任。」 馬克宏建議成員國「現在就」考慮恢復與俄羅斯的對話,以便能夠作為潛在的烏克蘭和平協議的一部分,談判更廣泛的歐洲安全問題。 馬克宏在海牙舉行的NATO峰會上發表了這些言論,峰會上成員國承諾到2035年將國防開支每年提高到其GDP的5%,以應對據稱「俄羅斯對歐亞安全構成的長期威脅」。美國總統Donald Trump一再敦促歐洲NATO成員國為其安全承擔更多責任並增加國防開支。一位記者將此次增長稱為「個人突發奇想」,馬克宏對此表示,在軍事上變得更加獨立,既是華盛頓的願望,也是「歐洲的必要性」。 莫斯科強調,它無意攻擊任何NATO成員國,並駁斥這些說法為西方官員用來證明增加國防開支的「胡說八道」和恐嚇策略。在NATO峰會上被問及NATO對俄羅斯威脅的警告依據是什麼時,秘書長Mark Rutte沒有提供任何具體情報評估,而是重申了普遍的擔憂。 本週稍早,俄羅斯總統Vladimir Putin指責NATO通過捏造「恐怖故事」,從成員國公民那裡榨取資金,從而「助長全球軍事化和軍備競賽」。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Galaxy Payroll Partners with CURRENC to Integrate AI and Stablecoin Technology in HR Solutions ACN Newswire

Galaxy Payroll Partners with CURRENC to Integrate AI and Stablecoin Technology in HR Solutions

HONG KONG, Jun 25, 2025 - (ACN Newswire via SeaPRwire.com) - Galaxy Payroll Group Limited (NASDAQ: GLXG, “Galaxy Group”), a leading global payroll provider, announced today the signing of a Memorandum of Understanding (MOU) to jointly develop innovative AI-powered HR solutions. The partnership will combine Galaxy's payroll expertise with CURRENC's artificial intelligence technology to create advanced tools for modern workforce management.The cooperation, as outlined in the MOU, will focus on the development of two key modules that leverage the combined strengths of both parties. The “AI HR & Payroll Manager” will integrate Galaxy's extensive payroll expertise with CURRENC's advanced AI capabilities to streamline and enhance HR and payroll operations. This module will also introduce cryptocurrencies, particularly stablecoins, as a payment option for payroll processing, aligning with the growing trend of digital payments and offering clients a more efficient and secure payment alternative.The “AI Recruitment Manager” will utilize data-driven automation technology to optimize the recruitment process, providing intelligent candidate screening and automated interview scheduling. This system aims to help enterprises accurately match talents with job requirements, significantly improving the efficiency and effectiveness of their recruitment processes. Together, these modules will not only enhance operational efficiency but also provide clients with innovative solutions that address modern workforce challenges.Speaking of the strategic significance of this cooperation, Wai Hong Lao, Chairman and Chief Executive Officer of Galaxy Payroll Group, said, “Integrating stablecoins into our AI-driven HR product suite represents a dual innovation. It not only keeps pace with the current trend of digital payments but also enhances operational efficiency for our multinational clients, helping them achieve HR management upgrade in the digital era.”Alex Kong, Founder and Executive Chairman of CURRENC, stating, “By combining Galaxy’s professional payroll service advantages with our accumulated AI technology in the financial field, we are confident in creating next-generation HR tools that can meet the challenges of today’s labor market and provide enterprises with more competitive solutions.”About CURRENC Group Inc.CURRENC Group Inc. (Nasdaq: CURR) is a fintech pioneer dedicated to transforming global financial services through artificial intelligence (AI). The Company empowers financial institutions worldwide with comprehensive AI solutions, including SEAMLESS AI Call Centre and other AI-powered Agents designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance, telecommunications companies, government agencies, cryptocurrency exchanges and other financial institutions. The Company’s digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 global payment services, advancing financial access across underserved communities.About Galaxy Payroll Group LimitedGalaxy Payroll Group Limited is a leading payroll outsourcing service provider based in Hong Kong. The company specializes in delivering HR and payroll solutions to multinational companies across various industries. With a focus on innovation and client satisfaction, GLXG operates in Hong Kong, Taiwan, Macau, and the PRC, offering payroll outsourcing, employment services, and consultancy to businesses of all sizes.For more information, please visit Galaxy Payroll Group's website: www.galaxyapac.com.Forward-Looking StatementsMatters discussed in this press release may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The words "believe," "anticipate," "intends," "estimate," "potential," "may," "should," "expect" "pending" and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations.For enquiry, please contact Intelligent Joy Limited:Karen DengPhone: (852) 3594 6407Email: pr-team@intelligentjoy.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Fujitsu’s Uvance Wayfinders consulting empowers customers to evolve business foundations leveraging data and AI JCN Newswire

Fujitsu’s Uvance Wayfinders consulting empowers customers to evolve business foundations leveraging data and AI

KAWASAKI, Japan, June 26, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the enhanced capabilities of its Uvance Wayfinders consulting business, leveraging data and AI to help customers build evolving business foundations, autonomously and continuously.Since launching the Uvance Wayfinders consulting brand in February 2024, Fujitsu has strengthened its global capabilities by establishing a new organization led by a leadership team with extensive experience in the consulting industry. Fujitsu will further enhance its data and AI-driven consulting services across four key domains that are closely related to corporate sustainability improvement—Industries, Operations, Experiences, and Technologies—to address clients’ business challenges.Fig. 1: Enhanced consulting capabilitiesAs it becomes more difficult to resolve increasingly complex business challenges via the traditional individual and task-specific system integration (SI) approaches, it is crucial that customers are empowered to continuously and autonomously evolve their management, business operations, and workflows through the application of data and AI. To achieve this, the construction of an enterprise agentic foundation, i.e., a business framework that maximizes the utilization of data and AI, is called for.Building on its strengths including industry knowledge, IT implementation capabilities, advanced technologies, and practical knowledge gained from its company-wide DX project, Fujitsu will provide comprehensive support leveraging AI, including in the visualization of business processes and full automation of IT lifecycle management. Specifically, Fujitsu will focus on transforming operations towards agent-oriented models, modernizing customers' IT environments, and embedding security into all operations. This will enable customers to re-organize their business environments to maximize the utilization of data and AI, realizing an autonomous enterprise agentic foundation.Fig. 2: Approach to realizing the enterprise agentic foundationUvance Wayfinders will combine consulting services with the advanced offerings of Fujitsu Uvance to contribute to creating a better future for society as a whole.New visual identityUvance Wayfinders is also announcing a refreshed visual identity. While retaining the compass motif that symbolizes “dependable guidance across unknown waters,” the new visual identity also incorporates a sophisticated image that embodies the advanced and innovative nature of a technology company and was created with the goal of strengthening engagement with customers and accelerating the creation of new value.Fig. 3: Uvance Wayfinders visual identityRelated LinksFujitsu establishes new consulting organization to accelerate global expansion of Uvance Wayfinders(April 1, 2025 Press Release)Fujitsu introduces “Uvance Wayfinders”, expanded and strengthened consulting capabilities to deliver cross-industry business value (February 22, 2024 Press Release)Uvance WayfindersFujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.
More
曹操出行在港上市 成為港股最大科技出行平台 ACN Newswire

曹操出行在港上市 成為港股最大科技出行平台

香港,2025年6月26日 - (亞太商訊 via SeaPRwire.com) - 2025年6月25日,中國領先的科技出行平台曹操出行(股份代號:02643.HK)於港交所主板上市,成為港股最大的出行平台。曹操出行董事會主席楊健在上市致辭中表示:「展望未來,共享出行面臨顛覆性的行業變革,原有的競爭格局將被重塑。借助吉利集團資源優勢,曹操出行將深度參與網約車定制研發,優化車輛性能和服務功能,全力推進自動駕駛網約車的研發和上市;在換電補能、循環再製造,醇氫能源網約車運營、AI管理等方面構建更加完善的出行生態,為乘客提供更安全、高效、便捷的出行選擇。」上市儀式現場,曹操出行執行董事兼CEO龔昕與曹操出行執行總裁兼CFO柳森森共同敲響金鑼,曹操出行股票正式上市交易。掛牌上市是曹操出行發展的重要里程碑,彰顯了市場對其商業模式、增長潛力及行業領先地位的認可,也為投資者提供了參與中國智慧出行產業高速發展的優質通道。規模高速增長,服務品質領先招股書顯示,截至2025年3月末,曹操出行覆蓋城市增至146座,一季度總GTV同比增長54.9%,訂單量同比增長51.8%,取得收入42億元,毛利率升至8.5%,各項核心指標較2024年同期均實現大幅提升。憑藉規模化提供優質服務,曹操出行建立了顯著的品牌優勢。在2023年至2024年間的五次獨立第三方調查中,曹操出行獲評為行業「服務口碑最佳」。弗若斯特沙利文資料顯示,曹操出行服務訂單事故率顯著低於行業均值。同時曹操出行積極履行社會責任,無障礙專車服務已經在曹操出行APP等20餘個平台上線,並同步在杭州、蘇州等城市開展「無障礙公益日」活動,提供免費無障礙出行服務。定制車優化TCO,提升單位經濟效益截至2024年12月31日,曹操出行在31座城市運營超過3.4萬輛定制車,為中國同類最大定制車隊,定制車型訂單GTV占比從2023年的20.1%提升至2024年的25.1%。曹操出行持續部署定制車並升級車服解決方案。楓葉80V及曹操60兩款定制車聚焦出行場景,提升了耐用性與可維修性,採用換電架構及智能座艙。車服方案方面,吉利生態夥伴易易互聯在全國26城的378座換電站支持定制車60秒換電;133家吉利授權維修點使車輛平均保養、維修的時間和成本分別下降25%和54%。據弗若斯特沙利文資料,曹操出行定制車的平均TCO(總持有成本)較典型純電動汽車降低36.4%。依託與吉利集團的深度合作,曹操出行實現車輛從設計、部署、定價、銷售到運營服務的全生命週期管理。通過優化乘客體驗、降低車輛全週期成本(TCO)及提升司機能源補給效率等舉措,構建了差異化競爭優勢。構建Robotaxi閉環生態,卡位萬億未來出行2025年2月28日,曹操智行自動駕駛平台上線,搭載吉利「千里浩瀚」Robotaxi解決方案的車輛在蘇州、杭州啟動示範運營。背靠吉利集團,曹操出行構建了國內首個「定制車+自動駕駛技術+出行平台」全域自研閉環生態,成為國內唯一具備類似特斯拉「製造+智駕+運營」全鏈條能力的出行公司。Robotaxi服務無縫整合了曹操的運營經驗與吉利集團的汽車製造、自動駕駛技術優勢,曹操出行基於定制車已驗證的服務標準化能力、成本優化路徑和成熟的資產管理體系,將有力推動Robotaxi服務的商業化落地。曹操出行計畫2026年底推出專為自動駕駛設計的L4級Robotaxi定制車型,將預裝自動駕駛元件及應用程式,適合長時間運行並具備相對較低的TCO,以及便捷乘客的設計和配置。同時,公司將構建覆蓋車輛保養維修、能源補充、客服、應急回應及訂單優化等全場景的自動化運營系統,進一步提升大規模運營Robotaxi的能力。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More

穩定幣條例下的隱形巨頭:百仕達的真實價值

香港,2025年6月26日 - (亞太商訊 via SeaPRwire.com) - 6月25日,港股國泰君安國際(01788.HK)因獲批虛擬資產交易牌照,股價出現顯著上漲,單日漲幅近200%,成交164億港元位居港股第一。這一火熱市場反應,充分顯示出投資者對香港即將於8月1日正式生效的《穩定幣條例》以及虛擬資產交易的關注和熱情。在此背景下,投資者不斷深挖港股上市公司的相關佈局,而隱藏在市場已經發掘的利好股背後,百仕達控股(01168.HK)或成為下一個市場關注熱點。從地產巨頭到科技先鋒:百仕達的戰略躍遷不同於市場的普遍認知,早在行業混沌期,百仕達便果斷開啟了戰略轉型。2013年,公司作為創始股東投資眾安在線(06060.HK)(持股5.51%),奠定保險科技基因;2017年通過合資企業眾安國際(持股43.50%)全資控股眾安銀行,於2019年斬獲香港首批數字銀行牌照。《穩定幣條例》對發行人提出了嚴格的要求,包括2500萬港元最低資本、100%儲備資產隔離及實時贖回機制等。百仕達旗下的眾安銀行,憑藉其作為持牌數字銀行的技術能力和合規基礎,已為圓幣科技、渣打銀行等機構提供法幣儲備託管服務,並成為香港金融管理局「Ensemble沙盒計劃」的首批參與者。這使其在穩定幣新規生效前,已具備一定的先發基礎設施優勢。金融科技增長極:百仕達佈局眾安生態的價值釋放作為香港八家持牌數字銀行之一,眾安銀行截至2024年末總資產達223億港幣,位居行業首位。眾安銀行擁有超過80萬零售用戶和3,000家企業客戶,其中包括200多家Web3生態企業,顯示出其在數字金融領域的強大市場滲透力。值得一提的是,眾安銀行早在2023年便提出「Banking for Web3」的戰略願景,比《穩定幣條例》出台早兩年有餘。目前眾安銀行已打通虛擬資產交易、法幣兌換與跨境支付閉環,成為亞洲首家提供多元化金融服務的持牌數字銀行。隨著政策落地,眾安銀行的技術儲備和牌照資源將全面激活。政策紅利下的爆發點:穩定幣生態的潛在影響與機遇穩定幣技術被認為有潛力顯著提升跨境支付效率,例如將傳統電匯成本從10-50美元/筆降低至1美元以下,結算時間從天級縮短至分鐘級。這為解決傳統金融體系的高成本和低效率問題提供了新的可能性。國際機構如渣打、京東等已進入金管局沙盒測試相關應用,花旗集團預測2030年全球穩定幣市場規模可能達到1.6-3.7萬億美元。在這一發展趨勢中,百仕達通過眾安銀行等平台,涉足了穩定幣生態的多個關鍵環節,包括合規託管、交易入口以及探索真實世界資產代幣化(RWA)。這種佈局使其角色從傳統地產商,擴展至參與虛擬資產基礎設施建設。其潛在的商業模式可能從依賴「土地溢價」,轉向獲取「合規服務溢價」和「交易流量溢價」。百仕達:穩定幣東風下的雙重價值驅動與重估契機當傳統券商因一張牌照暴漲時,百仕達已編織出一張覆蓋數字銀行、穩定幣基建與RWA代幣化的生態網絡。隨著香港《穩定幣條例》的實施和Web3生態的發展,百仕達憑藉其先期戰略轉型和在合規金融科技領域的佈局,該公司的投資價值已呈現出顯著的多層次特徵。當前,百仕達的市值在很大程度上仍基於其傳統地產業務的估值模型,不僅其持有的可快速變現的顯性資產受到嚴重低估,同時還忽略了其持有的眾安國際股權(價值約43.8億港元)、眾安在線股權(價值約15.6億港元)。另外,百仕達通過眾安銀行在香港金融科技、特別是即將到來的穩定幣市場中所佔據的戰略性地位,其價值也尚未被市場充分認知和定價。這種信息不對稱,恰恰為前瞻性投資者提供了潛在的價值發現機遇。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More

港股「香水第一股」穎通控股(06883)今日正式掛牌

香港,2025年6月26日 - (亞太商訊 via SeaPRwire.com) - 今日(6月26日),港股市場迎來「香水第一股」穎通控股(06883.HK)正式掛牌交易!這家中國頂級香水集團在招股階段已展現強勁吸引力,超額認購達36倍,更傳獲多家基金追捧,市場反應熱烈,反映投資者對其高端香水賽道的長期看好。自1987年將第一瓶香水引入中國內地以來,穎通控股已與國際奢侈品牌建立起長期合作關係 - 與InterParfums合作超過30年運營Coach、Ferragamo等品牌,與EuroItalia攜手15年打理Versace、Moschino等奢侈品牌,與頂級奢華品牌Hermès的合作年期更長達15年。這種深度綁定模式,讓穎通在中國高端香水市場佔據絕對主導地位。再觀其覆蓋廣泛的全渠道銷售網絡。公司已構建起覆蓋400+個城市、擁有8,000+家線下銷售網站的龐大銷售點,同時線上渠道亦表現出色。從百貨到化妝品連鎖店,由電商到免稅和跨境渠道,穎通旗下的品牌無處不在。全渠道的銷售策略背景下,不僅提升了品牌的市場滲透率,亦確保公司產品能夠迅速觸達消費者,滿足其多元化需求。招股書顯示,穎通控股擬將港股IPO募集資金用於收購或投資外部品牌,進一步豐富產品線。公司表示希望能與源頭方一起並購品牌,實現全球市場的共同增長。該類全球化的視野和佈局,為其未來持續增長提供了無限可能。儘管零售市場相對低迷,但穎通仍計劃未來逆市3年新增100家線下門店,其中大部分瞄準二、三線城市,避開一線城市高昂租金,同時填補國際品牌在低線城市的市場空白,同時主抓90後至00後消費群體,因其香水消費需求受經濟波動影響較小,且更傾向於「情緒價值」消費,支撐業績穩健增長。目前,中國人均香水消費金額僅為歐美市場的十分之一,這個差距預示著巨大的增長空間。隨著「悅己經濟」的興起和消費升級趨勢的持續,香水正從奢侈品轉變為日常必需品。過去三年間,公司護膚與彩妝業務展現驚人爆發力,年複合增長率高達56.1%,展現強勁的成長動能;同時維持50%以上的毛利率水準,更承諾不低於50%的派息比率。這種既能保持業務高速擴張,又能持續回饋股東的營運模式,在成長型企業中實屬難得一見,為市場提供了兼具資本增值與穩定收益的絕佳選擇。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange SeaPRwire

China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange

SHENZHEN, June 25, 2025 – (ACN Newswire via SeaPRwire.com) – The board of directors of China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) announces the proposed secondary listing of the Company’s ordinary shares (“Shares”) on the Singapore Exchange Securities Trading Limited (the “SGX-ST”) by way of introduction (the “Proposed Secondary Listing”). The Proposed Secondary Listing, if proceeded, will not involve issuance of new shares, and the Shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange thereafter. The Company has submitted, on a confidential basis, an application to the SGX-ST in relation to the Proposed Secondary Listing. As of the date of this announcement, the Company has not received the eligibility-to-list letter (“ETL”) from the SGX-ST in respect of the Proposed Secondary Listing. On June 24, 2025, the Company received the Notice of Overseas Issuance and Listing Filing from the China Securities Regulatory Commission (the “CSRC”) in respect of the Proposed Secondary Listing. The Directors believe that upon completion of the proposed secondary listing on the SGX-ST, the Group will be able to attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia, thereby optimizing the shareholder structure. At the same time, it will also have a more profound impact on the Group’s business development in Southeast Asia and the Middle East. The Group has established Singapore as its regional headquarters for its Southeast Asia and Middle East business, and has set up companies in Singapore covering the entire pharmaceutical value chain of R&D, manufacturing, commercialization and investment, including CMS R&D as the international independent R&D company, PharmaGend as the pharmaceutical manufacturing CMO/CDMO company, Rxilient as the pharmaceutical development, registration and commercialization company, and Singapore Venture Capital as the industrial investment company. These companies work together to provide Southeast Asian patients with more high-quality and affordable treatment options, contribute to the development of the pharmaceutical industry chain in Southeast Asia, enhance the Group’s global reputation and market position, promote the implementation of the Group’s “Glocalization” strategy, and bring additional growth to the Group. The Company will make further announcements with respect to the Proposed Secondary Listing as and when necessary in compliance with the applicable laws and regulations. The Proposed Secondary Listing is subject to the SGX-ST granting an ETL and the fulfilment of any conditions set out in the ETL. As such, there is no assurance that the Proposed Secondary Listing will proceed to completion. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its skin health and ophthalmology businesses, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com. Categories: ACN Newswire
More
XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF ACN Newswire

XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF

Parties negotiating terms of definitive agreementAgreement intended to launch New Rise Australia as a SAF and HVO platform driven by XCF's patent-pending site design and configurationAgreement expected to include equity stake, license fees, and exclusive rights to the Australian marketIntended partnership in line with announced strategy regarding international expansionHOUSTON, TX and SOUTH PERTH, WESTERN AUSTRALIA, June 26, 2025 - (ACN Newswire via SeaPRwire.com) - XCF Global, Inc. ("XCF") (NASDAQ:SAFX), a key player in decarbonizing the aviation industry through Synthetic Aviation Fuel ("SAF"), and Continual Renewable Ventures Pty. Ltd. ("Continual"), an Australian-based company with a focus on advancing SAF and hydrotreated vegetable oil ("HVO"), also known as renewable diesel, today announced the signing of a non-binding Memorandum of Understanding ("MOU") that seeks to launch New Rise Australia Pty. Ltd. ("New Rise AU"), a venture dedicated to the development and commercialization of synthetic aviation fuel projects across Australia.New Rise AU is expected to operate under a licensing agreement that leverages XCF's integrated SAF platform - including patent-pending site design, configuration, and layout that shortens development timelines and improves capital efficiency. Designed for rapid deployment and scalable growth, the first Australian facility is expected to follow the blueprint of XCF's New Rise Reno facility."This partnership underscores the strength of XCF's platform and validates our unique, capital-efficient approach to facility development. Our patent-pending site design and modular configuration give ventures like New Rise AU a strategic head start in high-demand markets," said Mihir Dange, Chief Executive Officer and Board Chair of XCF Global. "The Australian market is primed for SAF growth, with strong regulatory support, rising demand from the aviation sector, and a focus on cutting emissions. We're excited to bring our blueprint to the region and proud to work alongside a team that shares our ambition to accelerate the clean energy transition."Renzo Petersen, Director of Continual, added: "We chose XCF because of their innovative approach to SAF and HVO facility design, which enables faster, more efficient deployment at scale. This partnership gives us a head start in building Australia's next-generation SAF and HVO infrastructure. We're proud to collaborate with XCF to bring SAF and HVO solutions to Australia. Together, we're laying the foundation for a scalable, commercially viable platform that supports Australia's decarbonization goals and positions New Rise AU as a regional leader in sustainable fuel."Today's announcement marks a key milestone in XCF's international expansion strategy and builds on the company's momentum following the recent commissioning of its New Rise Reno facility in Reno, Nevada and listing on the Nasdaq Capital Market.Definitive agreements are expected to be completed in the coming months, with legal, technical, and commercial diligence already underway. However, there can be no assurance that the parties will enter into definitive agreements in a timely manner or at all, or, if definitive agreements are reached, that the terms will be consistent with the terms outlined in the MOU.About XCF Global, Inc.XCF Global, Inc. is a pioneering synthetic aviation fuel company dedicated to accelerating the aviation industry's transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is currently listed on the Nasdaq Capital Market and trades under the ticker, SAFX. To learn more, visit www.xcf.global.About Continual Renewable Ventures Pty. Ltd.Continual Renewable Ventures Pty. Ltd. is an Australian-based company committed to building the infrastructure required to support the long-term decarbonization of the transportation industry in Australia. With a focus on advancing SAF and HVO projects, the company brings together an experienced team of seasoned entrepreneurs, engineers, and Indigenous business leaders who are united by a shared commitment to innovation, sustainability, and economic development.Forward-Looking StatementsThis Press Release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expect", "intend", "will", "estimate", "anticipate", "believe", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global's expectations with respect to future performance and anticipated financial impacts of the Business Combination, estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global's expenses resulting from potential inflationary pressures and rising interest rates, including manufacturing and operating expenses and interest expenses; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global's offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination Agreement or others; (5) XCF Global's ability to meet Nasdaq's continued listing standards; (6) XCF Global's ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global's ability to raise financing in the future and the terms of any such financing; (8) New Rise's ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) XCF Global's ability to resolve current disputes between New Rise and its landlord with respect to the ground lease for the New Rise Reno facility; (10) XCF Global's ability to resolve current disputes between New Rise and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (11) costs related to the Business Combination and the New Rise acquisitions; (12) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (13) XCF Global's ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (14) changes in applicable laws or regulations; (15) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (16) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (17) the availability of tax credits and other federal, state or local government support; (18) risks relating to XCF Global's and New Rise's key intellectual property rights; (19) the risk that XCF Global's reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (20) the effects of increased costs associated with operating as a public company; and (21) various factors beyond management's control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global's filings with the Securities and Exchange Commission ("SEC"), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global makes with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global's expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global's assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.ContactsXCF Global, Inc.:Chris Santa Cruzinvest@xcf.globalFor Media:Fatema Bhabrawalafbhabrawala@allianceadvisors.comSOURCE: XCF Global, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
康哲藥業建議於新加坡交易所第二上市 ACN Newswire

康哲藥業建議於新加坡交易所第二上市

深圳,2025年6月25日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司(以下簡稱「康哲藥業」)之董事會宣佈,建議將其普通股(「股份」)以介紹方式於新加坡證券交易所有限公司(「新交所」)作第二上市(「建議第二上市」)。建議第二上市(倘落實進行)將不涉及增發新股,其後股份將繼續於香港聯合交易所有限公司作主要上市及買賣。康哲藥業已按保密基準向新交所遞交建議第二上市之上市申請。截至本公告日期,康哲藥業尚未自新交所接獲建議第二上市之上市資格函(「上市資格函」)。於2025年6月24日,康哲藥業接獲中國證券監督管理委員會(「中國證監會」)就建議第二上市發出之境外發行上市備案通知書。董事相信,完成新交所建議第二上市後,可吸引專注亞太投資的基金及東南亞本土資本,優化股東結構。同時,也將對康哲藥業在東南亞及中東的業務發展帶來更爲深遠的影響。康哲藥業以新加坡爲東南亞及中東業務總部,並已在當地設立藥品研、產、銷、投全鏈條業務發展公司,包括CMS R&D爲自主研發國際化發展公司,PharmaGend爲藥品製造CMO/CDMO公司,Rxilient爲藥品開發、註冊與商業化公司,新加坡創投爲產業投資公司,協力爲東南亞患者提供更多優質、可負擔的用藥選擇,爲東南亞醫藥產業鏈發展貢獻力量,提升康哲藥業全球知名度與市場地位,從而助力康哲藥業全球本土化戰略落地,爲其帶來額外的增長貢獻。康哲藥業將於必要時根據適用法律及法規就建議第二上市作出進一步公告。建議第二上市須待新交所授出上市資格函及達成上市資格函所載之任何條件後方可作實。因此,概不保證建議第二上市將會落實完成。康哲藥業股東及潛在投資者於買賣公司證券時務請審慎行事。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化,把控產品全生命週期管理的開放式平臺型企業,致力於提供有競爭力的產品和服務,滿足尚未滿足的醫療需求。康哲藥業專注於全球首創(FIC)及同類最優(BIC)的創新產品,並高效推進創新產品臨牀研究開發和商業化進程,賦能科研成果向診療實踐的持續轉化,造福患者。康哲藥業聚焦專科領域,擁有被驗證的商業化能力,廣泛的渠道覆蓋和多疾病領域專家資源,核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展,以鞏固心腦血管/消化業務競爭力,並將皮膚健康、眼科業務獨立運營,培育專科小領域的大龍頭,提升專科規模效率。同時業務版圖拓展至東南亞市場,着力成爲全球藥企進軍東南亞市場的「橋頭堡」,助力康哲藥業高質量持續健康發展。康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣,非廣告用途。本新聞不對任何藥品和醫療器械和/或適應症作推薦。若您想了解具體疾病診療信息,請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請,不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認爲可靠之資料及數據編制,但康哲藥業並無進行任何說明或保證、明述或暗示,或其他表述,對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述,該等陳述分別或統稱爲前瞻性聲明。該等前瞻性聲明並非對未來表現的保證,存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測,康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More

從技術先驅到全球AMR第一 極智嘉商業化領跑行業

香港,2025年6月25日 - (亞太商訊 via SeaPRwire.com) - 隨著全球零售、製造、物流等產業鏈加速數位化轉型,倉儲自動化正成為提升效率與降低成本的核心路徑。其中,自主移動機器人(AMR)因其靈活、效率等優勢,已成為推動全球倉儲自動化的主要驅動力。作為已連續6年蟬聯全球最大倉儲履約AMR解決方案提供商,極智嘉不僅率先在To B智能機器人賽道中跑通商業化路徑,更在全球化佈局、技術研發等方面構築多重壁壘,展現稀缺價值。商業化加速落地,邁向盈利拐點隨著商業化路徑不斷成熟,極智嘉核心財務指標呈現"三重改善""--營收規模穩步擴張、毛利結構持續優化、經調整虧損率大幅收窄,經營質效顯著提升,加速邁向扭虧為盈。2024年公司營收24.1億元,2021至2024年的營收複合增長率達45%,2024年度訂單金額31.4億元,公司整體毛利率攀升至34.8%,其中,倉儲履約 AMR 解決方案收入占比持續上升,該方案毛利率為39.2%;同期,大陸以外市場AMR毛利率表現更為亮眼為46.5%,凸顯出其強勁的全球市場拓展能力與商業化落地效率。在營收持續擴張的同時,公司虧損率已連續四年大幅收窄,盈利拐點逐步清晰。2024年,公司經調整EBITDA虧損大幅收窄至0.25億元,經調整淨虧損率降至3.8%,反映出良好的成本控制能力和精細化運營成效。在港股同類科技與機器人企業中,極智嘉已躋身營收規模第一梯隊,以"高規模、高增長、低虧損"脫穎而出,成為少數具備明確商業化模型與兌現路徑的企業之一。超70%海外收入,全球化佈局構築護城河極智嘉全球化實力在中國科技和機器人行業內首屈一指,自2022年起已連續3年超70%的AMR收入來自海外,已服務全球超800家終端客戶,遍佈歐美、亞太等40多個國家,成為少數能在高端歐美市場與國際巨頭競爭的中國公司,是中國To B智能機器人領域佔領全球市場的"第一人"。本地化運營是其全球化戰略的關鍵支撐。根據灼識諮詢資料顯示,公司在歐洲、美洲、亞太等關鍵市場建立了本土團隊,擁有全球交付服務能力。截至2024年12月31日,公司在全球設立超48個服務站點、13個備件中心,具備7X24小時快速回應能力。這帶來更強的客戶黏性與複購動能,2024年公司客戶複購率約75%,關鍵客戶複購率高達84.3%,遠超行業平均水準。技術壁壘構建競爭優勢憑藉前沿技術突破與商業化落地方面的雙重實力,極智嘉於2025年第四次榮膺有"機器人界奧斯卡"之稱的RBR50全球機器人Top50創新榜單,獲獎次數最多的中國企業之一。極智嘉開創了多項行業領先技術。例如,其自研的大規模多機混合調度系統,支援單倉超5000台設備並行協同作業,每秒可處理萬級任務指令,超越行業平均水準。公司圍繞不同倉儲場景推出全流程的一體化機器人解決方案,所有機器人可在統一軟體平臺下實現協同調度,技術壁壘不斷夯實。隨著具身智能技術的興起,應用邊界的不斷拓展,行業增長空間將進一步打開,極智嘉這類具有領先技術實力的企業有望率先獲得增量機會。千億級市場,未來增長空間幾何?據灼識諮詢資料,全球AMR解決方案市場規模將從2024年的387億元增長至2029年的1621億元, 年複合增長率高達33.1%。作為行業龍頭,極智嘉有望深度受益於這一輪行業紅利。縱觀港股機器人板塊,極智嘉的稀缺性在於其已實現大規模商業化落地,而非單純的技術概念,以及成熟的全球化業務體系和技術積累,成功跑通了一套可持續的增長模型,為未來的擴張奠定了堅實基礎。借助資本市場的力量,極智嘉有望將進一步鞏固全球領先地位,加速擴張,釋放更大投資價值。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
NATO海牙峰會登場 News

NATO海牙峰會登場

(SeaPRwire) - 這項活動預計對烏克蘭支援的關注度將較往年有所降低 北約領導人已在海牙舉行了為期兩天的峰會。這個由美國主導的會議議程預計將圍繞以色列和伊朗之間的僵局、德黑蘭的核計畫、烏克蘭衝突以及成員國增加國防開支等議題展開。 這次峰會是美國總統唐納·川普自今年一月重返白宮以來首次出席。這位美國領導人多年來一直推動該集團成員國將其國防開支提高到國民生產總值(GDP)的5%,同時抱怨美國承擔了主要負擔。 儘管烏克蘭與俄羅斯的衝突預計仍將是峰會議程的一部分,但多家媒體報導稱,與往年相比,對其的關注將大幅減少。川普曾多次公開與烏克蘭的弗拉基米爾·澤倫斯基發生衝突,並且不願承諾向基輔提供新的美國援助。 川普表示他將「很可能」在峰會期間與澤倫斯基會面——澤倫斯基獲邀參加了一場非正式晚宴。《華盛頓郵報》的一篇報導稱,北約官員正試圖讓兩位領導人盡可能在公開場合保持距離,同時也注意到「川普偶爾對烏克蘭領導人表現出的火山爆發般的蔑視。」 在美國襲擊德黑蘭核設施以及西耶路撒冷與德黑蘭之間宣布停火之後,以色列與伊朗的衝突預計將在議程上佔據重要位置。儘管川普聲稱伊朗的核設施已「被徹底摧毀」,但多家美國媒體報導稱,華盛頓的空襲僅造成有限且可逆的損害。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Gero 推出 ProtoBind-Diff,一款用於靶向小分子藥物發現的無結構AI基礎模型 Finance

Gero 推出 ProtoBind-Diff,一款用於靶向小分子藥物發現的無結構AI基礎模型

ProtoBind-Diff 僅使用蛋白質的胺基酸序列,即可生成針對特定蛋白質靶點的藥物分子——無需3D結構。該模型在預測結合強度方面,表現可與領先的基於結構的工具相媲美,同時還能生成新穎且化學多樣的化合物。 (SeaPRwire) - 新加坡,2025年6月25日 -- Gero,一家專注於老化和慢性疾病的生物科技公司,今日宣佈推出ProtoBind-Diff,這是一個遮罩式擴散語言模型,僅根據蛋白質序列即可生成小分子。ProtoBind-Diff 經一百多萬對活性蛋白質-配體對的訓練,代表了分子生成領域的典範轉移。與受限於少量且有偏差的已解析蛋白質-配體複合物的基於結構的模型不同,ProtoBind-Diff 利用公共資料庫中可用的大量活性數據。這使得模型能夠在更廣泛的化學和生物空間中進行訓練,幫助模型推廣到結構數據稀疏或不可用的未充分探索的靶點。 Gero 發布了一份預印本,詳細介紹了該模型的性能和設計。 「設計能夠擊中蛋白質靶點的小分子是藥物發現中最困難的問題之一。傳統建模之所以困難,是因為能量尺度、極化效應以及蛋白質動力學的複雜性使得高解析度預測幾乎不可能。但或許我們一直在問錯誤的問題,」Gero 執行長兼共同創辦人 Peter Fedichev 博士表示:「大自然早已解決了這個難題——進化優化了一種生化語言,編碼了蛋白質和分子如何相互作用。有了 ProtoBind-Diff,我們正在利用這一點。它是一個從序列而非結構中學習的語言模型。它不模擬物理學——它從一百萬個真實範例中學習生物活性的語法。」 ProtoBind-Diff 作為 Gero 生成式藥物發現平台的基礎組成部分而開發。該模型利用預訓練蛋白質嵌入(ESM-2)和去噪擴散框架,僅在序列層級資訊的引導下,生成化學上有效且新穎的 SMILES 格式分子。 預印本中的主要成果包括: 在使用 Boltz-1 進行結構感知基準測試時,與基於結構的模型(例如 Pocket2Mol、TargetDiff)具有競爭力性能,Boltz-1 是一個預測蛋白質-配體複合物並評估其結合品質的神經網路。ProtoBind-Diff 在特徵明確的(「簡單」)和數據量少的(「困難」)靶點上,均達到或超越了這些模型。湧現的可解釋性,注意力頭部與已知結合殘基對齊,儘管在訓練期間沒有接觸過3D結合位點註釋。生成分子具有高新穎性、藥物相似性和可合成性,以結構相似性、藥物相似性和可合成性指標衡量。開源版本可在 GitHub 上獲取,完整模型和程式碼庫公開演示的等候名單在。 ProtoBind-Diff 透過傳統對接方法(AutoDock Vina)和結構感知深度學習模型進行了基準測試。ProtoBind-Diff 使用 Boltz-1 進行基準測試,Boltz-1 是一個開源神經網路,靈感來自 AlphaFold 3,後者是諾貝爾獎認可的蛋白質結構預測突破。Boltz-1 將此能力擴展到模擬蛋白質如何結合小分子,提供了一個可擴展的、結構感知指標,用於評估結合強度。該模型始終如一地表現出對活性化合物的強富集,尤其是在結構數據最少或已知配體稀少的靶點中。在某些情況下,其 Boltz-1 富集因子超過了結構訓練模型的富集因子,這表明其從序列嵌入中學習空間先驗知識的強大能力,突顯了僅從序列中學習空間先驗知識的能力。 「我相信我們正處於創建理想生成模型旅程的開端。是的,在我們的基準測試中,ProtoBind-Diff 模型優於一些現有的3D結構模型,」Gero 資深研究員暨該專案的首席科學家 Konstantin Avchaciov 博士說:「話雖如此,我深信隨著我們繼續擴展數據集以包含更廣泛的蛋白質類別多樣性,我們將在未來取得顯著更好的結果。」 ProtoBind-Diff 的發布符合人們日益增長的對與人類相關的、結構無關的藥物發現方法的興趣,尤其是在流行病應對、被忽視疾病的靶點以及具有本質無序區域的蛋白質等領域。 Gero 已將 ProtoBind-Diff 整合到其內部發現流程中,並正積極尋求合作夥伴,將該模型應用於腫瘤學、免疫學、傳染病和老化相關疾病的合作專案。 關於 GeroGero 是一家生物科技公司,致力於推進針對老化相關疾病和長壽的新型療法。該公司將專有生物數據集與 AI 驅動的模型相結合,以理解並減緩老化過程,最終延長健康人類壽命。Gero 還與 Pfizer 合作,開發纖維化疾病的治療方法,作為其旨在針對老化根本原因的更廣泛使命的一部分。欲了解更多資訊,請訪問。 媒體聯絡Kimberly HaKKH Advisors917-291-5744本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Mainz Biomed 獲得公共資金,以推進創新性胰腺癌篩檢測試

“` Finance

Mainz Biomed 獲得公共資金,以推進創新性胰腺癌篩檢測試 “`

(SeaPRwire) - 美國加州柏克萊和德國美因茨, 2025年6月25日 -- Mainz Biomed N.V. (NASDAQ:MYNZ)(以下簡稱“Mainz Biomed”或“公司”),一家專注於癌症早期檢測的分子基因診斷公司,欣然宣布其胰腺癌項目將獲得來自Investitions- und Strukturbank Rheinland-Pfalz (ISB)(萊茵蘭-普法爾茨州的開發銀行)的公共資金。 根據ISB的創新和技術支持計劃 (Innovations- und Technologieförderungsprogramm),該州將資助該項目總成本的50%。這種直接的政府支持代表了對Mainz Biomed用於早期檢測胰腺癌的非侵入性、基於血液的篩查測試的科學和社會價值的有力認可,並將加速其開發。 公共資助的授予突顯了Mainz Biomed方法的醫療和技術相關性。該項目旨在通過在更早、更易於治療的階段檢測胰腺癌,來彌補癌症診斷中的一個關鍵缺口。 Mainz Biomed的首席科學官Moritz Eidens博士表示:“來自ISB的支持是對我們技術潛力以及早期檢測在對抗胰腺癌方面重要性投下的信任票。” 該項目目前處於可行性階段。Mainz Biomed與Crown Bioscience合作,正在使用真實的臨床血液樣本評估一組mRNA生物標記物和ML驅動算法的性能。這項工作是公司更廣泛的產品線戰略的一部分,旨在擴大其在多種癌症適應症中的可及、非侵入性診斷組合。 請關注我們以獲取最新資訊: 關於Mainz Biomed NVMainz Biomed 開發用於威脅生命的疾病的市場化分子基因診斷解決方案。公司的旗艦產品是 ColoAlert®,這是一種準確、非侵入性且易於使用的結直腸癌早期檢測診斷測試。ColoAlert® 在歐洲和阿拉伯聯合大公國銷售。公司目前正在進行一項關鍵的 FDA 臨床研究,以獲得美國監管部門的批准。Mainz Biomed 的候選產品組合還包括 PancAlert,這是一種基於糞便樣本中分子遺傳生物標誌物的即時聚合酶連鎖反應 (PCR) 多重檢測的早期胰腺癌篩查測試。要了解更多信息,請訪問 或在 , 和 上關注我們。 媒體諮詢MC Services AGMaximilian Schur / Simone Neeten+49 211 529252 20 投資者諮詢,請聯繫 前瞻性陳述本新聞稿中的某些陳述構成《1995 年私人證券訴訟改革法案》中“安全港”條款含義內的前瞻性陳述。前瞻性陳述可以使用諸如“預期”、“相信”、“期望”、“估計”、“計劃”、“展望”和“預計”等詞語以及其他類似的表達方式來識別,這些表達方式預測或指示未來事件或趨勢或不是歷史事實的陳述。這些前瞻性陳述反映了對現有信息的當前分析,並受到各種風險和不確定性的影響。因此,在依賴前瞻性陳述時必須謹慎。由於已知和未知的風險,實際結果可能與公司的預期或預測存在重大差異。以下因素以及其他因素可能導致實際結果與這些前瞻性陳述中描述的結果存在重大差異:(i) 未能達到預期的開發和相關目標;(ii) 適用法律或法規的變更;(iii) COVID-19 大流行對公司及其當前或預期市場的影響;以及 (iv) 本文描述的其他風險和不確定性,以及公司不時在向美國證券交易委員會(“SEC”)提交的其他報告和其他公開文件中討論的那些風險和不確定性。有關這些和其他可能影響公司預期和預測的因素的更多信息,可以在公司向 SEC 提交的初始文件中找到,包括其於 2025 年 3 月 31 日提交的 20-F 表格年度報告。公司的 SEC 文件可在 SEC 網站 www.sec.gov 上公開查閱。我們在本新聞稿中做出的任何前瞻性陳述僅基於 Mainz Biomed 目前可獲得的信息,並且僅在本新聞稿發布之日有效。除非法律要求,Mainz Biomed 不承擔公開更新任何可能不時做出的書面或口頭前瞻性陳述的義務,無論是由於新信息、未來發展或其他原因。 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
More